Cepheid
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring
The test quantifies mutant NPM1 mRNA transcripts in peripheral blood specimens from patients with acute myeloid leukemia.